Skip to Content

REV 25 mg (Revlimid 25 mg)

Generic Name: lenalidomide

Pill with imprint REV 25 mg is White, Capsule-shape and has been identified as Revlimid 25 mg. It is supplied by Celgene Corporation.

Revlimid is used in the treatment of multiple myeloma; myelodysplastic diseases; lymphoma; anemia; mantle cell lymphoma and belongs to the drug classes miscellaneous antineoplastics, other immunosuppressants. Not for use in pregnancy. Revlimid 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for REV 25 mg


Generic Name:
REV 25 mg
25 mg
Prescription only
Drug Class:
Miscellaneous antineoplastics
Other immunosuppressants
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Celgene Corporation
Inactive Ingredients:
lactose anhydrous
microcrystalline cellulose
croscarmellose sodium
magnesium stearate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.